Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs)

被引:29
作者
Fischer, JA [1 ]
Muff, R [1 ]
Born, W [1 ]
机构
[1] Univ Zurich, Res Lab Calcium Metab, Dept Orthopaed Surg & Med, Klin Balgrist, CH-8008 Zurich, Switzerland
关键词
adrenomedullin; calcitonin-gene-related peptide; calcitonin receptor; calcitonin-receptor-like receptor; heterodimeric complex;
D O I
10.1042/bst0300455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The calcitonin (CT) receptor (CTR) and the CTR-like receptor (CRLR) are close relatives within the type 11 family of G-protein-coupled receptors, demonstrating sequence identity of 50%. Unlike the interaction between CT and CTR, receptors for the related hormones and neuropeptides amylin, CT-gene-related peptide (CGRP) and adrenomedullin (AM) require one of three accessory receptor-activity-modifying proteins (RAMPs) for ligand recognition. An amylin/CGRP receptor is revealed when CTR is co-expressed with RAMP1. When complexed with RAMP3, CTR interacts with amylin alone. CRLR, initially classed as an orphan receptor, is a CGRP receptor when co-expressed with RAMP1. The same receptor is specific for AM in the presence of RAMP2. Together with human RAMP3, CRLR defines an AM receptor, and with mouse RAMP3 it is a low-affinity CGRP/AM receptor. CTR-RAMP1, antagonized preferentially by salmon CT-(8-32) and not by CGRP-(8-37), and CRLR-RAMP1, antagonized by CGRP-(8-37), are two CGRP receptor isotypes. Thus amylin and CGRP interact specifically with heterodimeric complexes between CTR and RAMP1 or RAMP3, and CGRP and AM interact with complexes between CRLR and RAMP1, RAMP2 or RAMP3.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 43 条
[1]   A cDNA encoding the calcitonin gene-related peptide type 1 receptor [J].
Aiyar, N ;
Rand, K ;
Elshourbagy, NA ;
Zeng, ZZ ;
Adamou, JE ;
Bergsma, DJ ;
Li, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11325-11329
[2]   MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF A 3RD ISOFORM OF THE HUMAN CALCITONIN RECEPTOR AND PARTIAL CHARACTERIZATION OF THE CALCITONIN RECEPTOR GENE [J].
ALBRANDT, K ;
BRADY, EMG ;
MOORE, CX ;
MULL, E ;
SIERZEGA, ME ;
BEAUMONT, K .
ENDOCRINOLOGY, 1995, 136 (12) :5377-5384
[3]   Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells [J].
Aldecoa, A ;
Gujer, R ;
Fischer, JA ;
Born, W .
FEBS LETTERS, 2000, 471 (2-3) :156-160
[4]  
BEAUMONT K, 1993, MOL PHARMACOL, V44, P493
[5]   A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1 [J].
Bühlmann, N ;
Leuthäuser, K ;
Muff, R ;
Fischer, JA ;
Born, W .
ENDOCRINOLOGY, 1999, 140 (06) :2883-2890
[6]   Glycosylation of the calcitonin receptor-like receptor at Asn60 or Asn112 is important for cell surface expression [J].
Bühlmann, N ;
Aldecoa, A ;
Leuthäuser, K ;
Gujer, R ;
Muff, R ;
Fischer, JA ;
Born, W .
FEBS LETTERS, 2000, 486 (03) :320-324
[7]   Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene [J].
Caron, KM ;
Smithies, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) :615-619
[8]   IDENTIFICATION OF A 7 TRANSMEMBRANE HELIX RECEPTOR FOR CORTICOTROPIN-RELEASING FACTOR AND SAUVAGINE IN MAMMALIAN BRAIN [J].
CHANG, CP ;
PEARSE, RV ;
OCONNELL, S ;
ROSENFELD, MG .
NEURON, 1993, 11 (06) :1187-1195
[9]   Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors [J].
Chen, WJ ;
Armour, S ;
Way, J ;
Chen, G ;
Watson, C ;
Irving, P ;
Cobb, J ;
Kadwell, S ;
Beaumont, K ;
Rimele, T ;
Kenakin, T .
MOLECULAR PHARMACOLOGY, 1997, 52 (06) :1164-1175
[10]   Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product [J].
Christopoulos, G ;
Perry, KJ ;
Morfis, M ;
Tilakaratne, N ;
Gao, YY ;
Fraser, NJ ;
Main, MJ ;
Foord, SM ;
Sexton, PM .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :235-242